Invention Grant
- Patent Title: 2-oxo-thiazole derivatives as A2A inhibitors and compounds for use in the treatment of cancers
-
Application No.: US16354022Application Date: 2019-03-14
-
Publication No.: US10995101B2Publication Date: 2021-05-04
- Inventor: Stefano Crosignani , Bruno Gomes , Erica Houthuys
- Applicant: iTeos Therapeutics SA
- Applicant Address: BE Gosselies
- Assignee: iTeos Therapeutics SA
- Current Assignee: iTeos Therapeutics SA
- Current Assignee Address: BE Gosselies
- Agency: Goodwin Procter LLP
- Priority: EP17163781 20170330,EP17194084 20170929,ARP2018010778 20180328
- Main IPC: C07D513/14
- IPC: C07D513/14 ; C07D497/14 ; A61P35/00
Abstract:
The present invention relates to compounds of Formula I or pharmaceutically acceptable salts or solvates thereof. The invention further relates to the use of the compounds of Formula I as A2A inhibitors. The invention also relates to the use of the compounds of Formula I for the treatment and/or prevention of cancer. The invention also relates to a process for manufacturing compounds of Formula I.
Public/Granted literature
- US20190276473A1 2-Oxo-Thiazole Derivatives as A2A Inhibitors and Compounds for Use in the Treatment of Cancers Public/Granted day:2019-09-12
Information query
